KV Cuts Makena Price 54%, Increases Medicaid Rebates, But Is It Enough?
This article was originally published in The Pink Sheet Daily
Executive Summary
Bowing to public pressure and following an unusual intervention by FDA, KV Pharmaceuticals announced it has cut the list price of its new preterm birth prevention drug from $1,500 to $690 per injection.